Telix Pharmaceuticals Limited has released a press release.
FDA Approves Telix Brain Cancer Imaging Drug Pixclara
Earlier from Telix Pharmaceuticals
- Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference
- Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway
- Telix Appoints David Gill as Chair
- Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline